Relevance of the Evaluation Criteria Used in Clinical Trials for Alzheimer's Disease
Thérapie, 64 3 (2009) 145-148
Published online: 2009-08-13
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Efficacy and safety of DMB-I (latrepirdine) therapy in mild to moderate dementia in Alzheimer’s disease: results of a multicenter, double-blind, randomized, placebo-controlled, clinical trial in three parallel groups
Boris I. Gorin, Stanislav O. Pozdnyakov, Ksenia A. Potapova, Elena A. Tukhovskaya and Dmitriy S. GorchakovScientific Reports 16 (1) (2026)
https://doi.org/10.1038/s41598-026-49538-4
Vitamin D and Cognition: Recommendations for Future Trials
Cedric Annweiler and Olivier BeauchetJournal of the American Geriatrics Society 61 (6) 1049 (2013)
https://doi.org/10.1111/jgs.12287
Effectiveness of the Combination of Memantine Plus Vitamin D on Cognition in Patients With Alzheimer Disease
Cédric Annweiler, François R. Herrmann, Bruno Fantino, Bernard Brugg and Olivier BeauchetCognitive and Behavioral Neurology 25 (3) 121 (2012)
https://doi.org/10.1097/WNN.0b013e31826df647